Excalipoint Therapeutics News and Activities

Acquisition, funding and merger involving Excalipoint Therapeutics.

• Excalipoint Therapeutics has just announced a $68 Million fundraising (posted on May 7 2026).

View the org chart displaying its 9 main executives

Most searched biographies at Excalipoint Therapeutics

• Lei Fang, Chief Executive Officer
• Cong Shen, Vice President, Chemistry, Manufacturing and Controls
• Jielun Zhu, Chief Financial and Business Officer

Create your alert
to follow the executive moves at Excalipoint Therapeutics.

Excalipoint Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Excalipoint Therapeutics

Social media about Excalipoint Therapeutics

• Excalipoint Therapeutics on Wikipedia, Google News & Yahoo Finance
• Excalipoint Therapeutics on LinkedIn, X (Twitter) & YouTube